COMMUNIQUÉS West-GlobeNewswire

Wright Medical Group N.V. Announces Pricing of Public Offering of Ordinary Shares
28/08/2018
AMSTERDAM, The Netherlands, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced the pricing of its previously announced registered underwritten public offering of 18,248,932 of its [...]
EB Research Partnership and EB Research Foundation Join Forces to Advance Breakthroughs in Epidermolysis Bullosa Research
28/08/2018
The two leading global nonprofits announce a partnership to combine resources to heal EB NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- EB Research Partnership (EBRP), based in New York, and Australian-based EB Research [...]
Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema
27/08/2018
- In the pivotal study, patients taking TAKHZYRO 300 mg every 2 weeks had an 87% reduction in mean monthly attacks vs. placebo (0.26 vs. 1.97, n=27 vs. n=41) - All secondary endpoints were met and included reduction in [...]
Veritas Completes Share Purchase Agreement with 3 Carbon Extractions Inc.
27/08/2018
VANCOUVER, British Columbia, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that the Company has completed the [...]
Akcea and Ionis Receive Complete Response Letter for WAYLIVRA from FDA
27/08/2018
CAMBRIDGE, Mass. and CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA) an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), today announced [...]
Tetraphase Pharmaceuticals Announces FDA Approval of XERAVA™ (Eravacycline) for Complicated Intra-Abdominal Infections (cIAI)
27/08/2018
– XERAVA™ Achieved High Clinical Cure Rates in Clinical Trials in Patients with cIAI – – Broad Product Label for Treatment of cIAI – – Commercial Launch Expected in the Fourth Quarter of 2018 – – Conference Call [...]
XBiotech annonce la publication de résultats décisifs sur le rôle potentiel de l'Interleukine-1 alpha dans le risque des crises cardiaques
27/08/2018
Les résultats montrent la capacité de MABp1 (Bermekimab) à bloquer l'activation endothéliale vasculaire par neutrophile in vitro et la thrombose AUSTIN, Texas, 27 août 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: [...]
Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager-based Immunotherapeutics for Multiple Cancer Targets
27/08/2018
Affimed will receive $96 million upfront and committed funding and is eligible for up to an additional $5.0 billion including milestone payments, and royalties on sales Heidelberg, Germany, August 27, 2018 - Affimed N.V [...]
Alphatec to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
27/08/2018
CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through [...]
K2M Group Holdings, Inc. to Participate in Two Investor Conferences in September
27/08/2018
LEESBURG, Va., Aug. 27, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional [...]
Editas Medicine Announces Transition of Chief Medical Officer
27/08/2018
CAMBRIDGE, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that its Chief Medical Officer, Gerald Cox, M.D., Ph.D., will be stepping down [...]
Wright Medical Group N.V. Announces Proposed Public Offering of Ordinary Shares
27/08/2018
Offering of $440 Million Ordinary Shares AMSTERDAM, The Netherlands, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced the commencement of a registered underwritten public [...]
Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Europe for the Treatment of Mucopolysaccharidosis VII
27/08/2018
Mepsevii, an Enzyme Replacement Therapy, is the First Treatment Approved in the EU for Mucopolysaccharidosis VII NOVATO, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a [...]
National Brain Tumor Society Statement on Passing of Sen. John McCain
27/08/2018
Boston, MA , Aug. 27, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society is profoundly saddened to learn of the senator’s passing, and our thoughts immediately go out to his family, friends, staff, colleagues and [...]
La Costa Glen Retirement Community Named Great Place to Work
27/08/2018
CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- The La Costa Glen continuing care retirement community in Carlsbad, California, has been certified as a top workplace by the independent research and consulting firm [...]
Biosenta Announces Signing Exclusive Global Royalty Agreement
27/08/2018
TORONTO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Biosenta Inc. (CSE: ZRO) is pleased to announce, in conjunction with Microbial Research Products, the Joint Venture (JV) Agreement announced on February 28, 2018, it has signed [...]
Cognoa Demonstrates Advances of its AI-Based Technology for Identifying Autism in Children
27/08/2018
Two clinical studies published in peer-reviewed journals validate continued accuracy improvements of the company’s artificial intelligence (AI) platform PALO ALTO, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Cognoa, a [...]
NeuroMetrix to Present at H.C.Wainwright & Co 20th Annual Global Investment Conference in New York City
27/08/2018
Presentation Shifted to 10:00 am on September 6, 2018 WALTHAM, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) reported that the time previously announced for its presentation at the H.C. [...]
DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company
27/08/2018
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]

Pages